Indication
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
1 clinical trial
1 product
Clinical trial
Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb InfectionsStatus: Completed, Estimated PCD: 2022-08-30
Product
Tebipenem